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Autoallergy is a phenomenon found in a subgroup of patients with atopic dermatitis (AD). These patients exhibit
serum IgE reactivity toward autoantigens like the alpha-chain of the nascent polypeptide-associated complex
(a-NAC; Hom s 2). a-NAC has been shown before to induce T-cell proliferation and secretion of IFN-g. To
elucidate the immune modulating functions a-NAC may exert, we analyzed its effects on cytokine transcription
and secretion in peripheral blood mononuclear cells (PBMCs), monocytes, and CD4þ T cells. Transcription and
secretion of IFN-g, IL-17, and IL-22 were increased in a-NAC-stimulated PBMCs. As IL-17 was significantly
upregulated by a-NAC, we assessed signal transduction in PBMCs and found signal transducer and activator of
transcription 3 phosphorylation in a-NAC-stimulated cells. Furthermore, we could show the importance of
monocyte activation by a-NAC, as isolated T cells reacted only weakly toward the stimulation. Inhibition of IL-23
p19 led to lower amounts of IL-17 in the PBMC supernatants after a-NAC stimulation. a-NAC stimulation of
PBMCs from non-allergic donors resulted in secretion of IL-10, which was greatly reduced in PBMCs from a-NAC-
sensitized AD patients. Our findings provide insights into the mechanisms of autoallergy, investigating the
interplay of immune cells, signaling events, and cytokines, which are known to be relevant in atopic skin
inflammation.
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INTRODUCTION
The autoallergen Hom s 2 or a-NAC (alpha-chain of the
nascent polypeptide-associated complex) belongs to a group
of autoallergens without known cross-reactivity to exogenous
allergens. These autoallergens (Hom s 1–5) have been identi-
fied by screening of a human epithelial complementary DNA
library for IgE binding of sera from atopic dermatitis (AD)
patients (Natter et al., 1998; Valenta et al., 1998). Besides its
allergenic potential, a-NAC is an intracellular protein, which
is involved in sorting of newly synthesized polypeptides
(Wiedmann et al., 1994), and acts as a transcriptional
coactivator (Yotov et al., 1998).
Mossabeb et al. (2002) already showed proliferation of
peripheral blood mononuclear cells (PBMCs) stimulated with
a-NAC, which was higher in IgE-sensitized patients than in
non-sensitized controls. This pointed to the involvement of
a-NAC-reactive T cells. In addition, the T-cell cytokine IFN-g
is produced in high amounts by a-NAC-stimulated PBMCs,
which has been shown to damage keratinocytes and could
thereby lead to further impairment of the epithelial barrier and
to worsening of skin inflammation (Mittermann et al., 2008).
Previously, we analyzed T-cell responses to a-NAC in IgE-
sensitized AD patients (Heratizadeh et al., 2011). We could
show that a-NAC induced preferential proliferation in the
cutaneous lymphocyte-associated antigenþ , i.e., skin-
homing, T-cell subsets from PBMCs. CD4þ T-cell clones
were generated from blood and skin of the patients, which
showed a predominant Th0 and Th1 cytokine profile,
respectively, and some skin-derived clones also produced
IL-17. From the blood, CD8þ T-cell clones could be
generated and these produced mainly IFN-g.
Although IFN-g clearly has been shown to have a role in the
chronic phase of AD, the situation is less conclusive for IL-17
and IL-22. IL-17 has been shown to be increased in acute AD
lesions, whereas IL-22 seems to have a role in chronic AD
lesions (Souwer et al., 2010). Cutaneous sensitization through
the impaired skin barrier typical of AD could influence the
cytokine pattern, which has been shown recently for epicu-
taneous sensitization with ovalbumin in a mouse model (He
et al., 2007). In this model, epicutaneous sensitization favored
the development of IL-17-secreting CD4þ T cells. As sensiti-
zation to autoallergens relevant in AD is most probably
initiated in the skin, where intracellular antigens can be
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released from stressed or damaged cells (Schmid-
Grendelmeier et al., 2005; Balaji et al., 2011), a similar
mechanism could apply for those molecules. Furthermore,
autoallergens seem to have intrinsic Th1-favoring properties
that distinguish them from exogenous allergens (Aichberger
et al., 2005; Mittermann et al., 2008).
In order to investigate the development and the possible
consequences of a-NAC autoallergy, this study aimed to
further analyze the cytokine response a-NAC elicits in mono-
nuclear cells and the underlying signaling events. In PBMCs,
transcription and secretion of T-cell cytokines was induced
most efficiently by the combined stimulation with a-NAC and
IL-2. This combination was also most effective in triggering
signal transducer and activator of transcription 3 (STAT3)
phosphorylation in PBMCs. We could also show monocyte
dependency of T-cell cytokine induction in PBMCs. Finally, a
significant difference was observed regarding IL-10 secretion
in PBMCs from control donors and from a-NAC-sensitized AD
patients, which could have a role in disease exacerbation in
the sensitized patients.
RESULTS
a-NAC induces high amounts of IFN-c, IL-17, and IL-22
Secretion of IFN-g and IL-10 has been described for a-NAC-
stimulated PBMCs (Mittermann et al., 2008) and there are
hints from T-cell clone analyses that a-NAC might promote
Th17 responses (Heratizadeh et al., 2011). Here, we
stimulated PBMCs with a-NAC in the presence or absence
of IL-2 and analyzed cytokines in supernatants and on mRNA
expression level. a-NAC alone was not sufficient to upregulate
secretion of the T-cell cytokines IFN-g and IL-22, but both
cytokines were produced after the combined stimulation of
PBMCs with a-NAC and IL-2 (Figure 1a). Stimulation with
a-NAC alone led to significant secretion of IL-17, albeit in very
low levels. Higher amounts of IL-17 were secreted by PBMCs
after stimulation with a-NAC and IL-2. In addition, transcrip-
tion of IFN-g, IL-17, and IL-22 was upregulated in PBMCs
(Figure 1b). Interestingly, transcription of IFN-g and IL-17 was
also induced by stimulation with a-NAC alone, but still less
than by the combined stimulation with IL-2. In contrast,
transcription of IL-17F was not upregulated by a-NAC (data
not shown). As cytokine induction varied considerably
between the donors, selected data of Figure 1 and the
following figures are plotted in line graphs in Supplementary
Figure S3 online.
Monocytes are important for induction of T-cell cytokines by
a-NAC
We have recently shown that a-NAC activates monocytes and
induces secretion of the proinflammatory cytokines IL-12 p40
and IL-6 in these cells (Hradetzky et al., 2013). To investigate
the importance of monocyte activation for the T-cell response,
we stimulated PBMCs as well as isolated CD4þ T cells with
a-NAC. Although the T-cell cytokines IL-17 and IL-22 were
strongly induced by a-NAC in PBMCs (Figures 1 and 2a),
isolated CD4þ T cells reacted only weakly to stimulation
with a-NAC (Figure 2a).
Similarly, CD4þ T cells that were incubated with super-
natants from monocytes stimulated with a-NAC secreted
higher levels of IL-17 and IL-22 compared with directly
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Figure 1. Alpha-chain of the nascent polypeptide-associated complex (a-NAC) induces secretion and transcription of T-cell cytokines. Peripheral blood
mononuclear cells (PBMCs) from atopic dermatitis (AD) patients and control donors were stimulated with a-NAC (2.5mg ml–1), IL-2 (50 U ml–1), or a combination
of both for 72 hours (a) or 8 hours (b). Supernatants were measured for levels of IFN-g, IL-17, and IL-22 by ELISA (a) and relative levels of mRNA were determined
by reverse-transcriptase–quantitative PCR (RT–qPCR) and normalized to glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA (b). Medians are shown.
*Po0.05, **Po0.01, ***Po0.001.
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stimulated CD4þ T cells (Figure 2b). However, cytokine
levels were still higher when PBMCs were stimulated with
a-NAC, indicating a role for cell contact between monocytes
and CD4þ T cells for efficient T-cell stimulation.
IL-23 is a Th17-promoting cytokine produced by monocytes
and dendritic cells that binds to the IL-12Rb1/IL-23R complex
followed by STAT3 activation. To find out if IL-23 is important
in a-NAC-induced upregulation of IL-17, we analyzed mRNA
expression and cytokine secretion in PBMCs. Expression of
IL-23A was higher in a-NAC-stimulated PBMCs than in medium
controls (Figure 3a). Although IL-23 levels in PBMC super-
natants were only weakly increased after a-NAC stimulation
(Figure 3b), pre-treatment of PBMCs with a blocking antibody
against IL-23 p19 led to reduced levels of secreted IL-17
(Figure 3c). IL-22 secretion was not significantly reduced
by the IL-23 p19 blockade (Figure 3c). In contrast, pre-
treatment of PBMCs with blocking antibody against IL-12
p40, which in addition to IL-23 also blocks IL-12 p70,
diminished the secretion of IL-17 and IL-22 (Supplementary
Figure S1 online).
STAT3 phosphorylation is essential for a-NAC-induced cytokine
effects
STAT3 is a key transcription factor for the differentiation of
Th17 cells as well as for IL-17 production, as it regulates
retinoic acid-related orphan receptor-gt expression and binds
directly to the Il17a locus (Chen et al., 2006). In accordance
with this, the combination of a-NAC and IL-2, which
upregulated IL-17 transcription and secretion most
efficiently, led to the strongest phosphorylation of STAT3 in
PBMCs (Figure 4a and b). Other STATs known to have a role
in T-cell activation and differentiation, such as STAT1, STAT4,
and STAT5, were not phosphorylated in PBMCs stimulated
with a-NAC (data not shown). To elucidate the role of STAT3
regarding the cytokine effects of a-NAC, we pre-treated the
cells with the specific STAT3-inhibitor Stattic before stimula-
tion. Stattic, but not the solvent DMSO alone, efficiently
reduced STAT3 phosphorylation (Figure 5a and b) and,
subsequently, also decreased the levels of the cytokines
induced by a-NAC or a-NAC and IL-2 (Figure 5c). 7-Amino-
actinomycin D staining of PBMCs after 3 days incubation with
Stattic revealed no decrease of cell viability (Figure 5d).
Furthermore, PBMCs pre-treated with Stattic or DMSO were
still responsive to stimulation with Staphylococcus enterotoxin
B (Figure 5e). This emphasizes the importance of STAT3 for
the effects of a-NAC.
Despite the effective IL-17 induction and STAT3 phosphor-
ylation by a-NAC, we could not observe an effect on retinoic
acid-related orphan receptor-gt in terms of changes in mRNA
expression (data not shown).
PBMCs of a-NAC-sensitized AD patients fail to secrete IL-10 in
response to a-NAC
All experiments described above have been performed with
PBMCs and isolated monocytes or CD4þ T cells from AD
patients as well as from control donors. For most of the analyzed
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Figure 2. Monocytes are important for induction of T-cell cytokines by the alpha-chain of the nascent polypeptide-associated complex (a-NAC). Peripheral
blood mononuclear cells (PBMCs) and CD4þ T cells from the same donors were stimulated with a-NAC (2.5mg ml–1), IL-2 (50U ml–1), or a combination of both
for 72 hours (a). Isolated monocytes were stimulated with a-NAC (2.5mg ml–1), IL-2 (50 U ml–1), or a combination of both for 72 hours. Isolated CD4þ T cells were
incubated with these supernatants for 72 hours. For comparison, PBMCs and isolated CD4þ T cells from the same donors were stimulated with a-NAC
(2.5mg ml–1), IL-2 (50 U ml–1), or a combination of both for 72 hours (b). Supernatants were measured for levels of IL-17 and IL-22 by ELISA. Medians are shown.
**Po0.01. SN, supernatant.
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cytokines, there were no significant differences between the
AD patients and the controls, however, when we analyzed
IL-10 levels in supernatants from PBMCs stimulated with
a-NAC, it became evident that the control group secreted
high amounts of IL-10, whereas in the group of AD patients
sensitized to a-NAC IL-10 levels were significantly lower
(Figure 6a). PBMCs from AD patients that were not sensitized
to a-NAC released similar levels of IL-10 compared with the
control donors. The reduced IL-10 levels in supernatants from
cells of AD patients sensitized to a-NAC was not due to their
general inability to secrete IL-10, as this cytokine was pro-
duced in response to human thioredoxin (median: 195 pg ml–1,
range 49–1,560 pg ml–1). Thioredoxin may act as an autoaller-
gen in some patients with AD, our patients were, however, not
sensitized to this protein. To find out which cell subset of the
PBMCs is responsible for the observed IL-10 production, we
stimulated PBMCs, monocytes, and CD4þ T cells of the same
control donors. As shown in Figure 6b, monocytes secreted IL-
10 in comparable amounts to the corresponding PBMCs. In
CD4þ T-cell supernatants, only very low levels of IL-10 were
detected. This finding underlines again the impact of mono-
cytes in generating an immune response to a-NAC.
DISCUSSION
AD is a chronic inflammatory skin disease characterized by a
dysregulated immune response as well as skin barrier defects.
Allergen-specific T cells are major skin-infiltrating effector
cells of the disease, with a Th2 bias in the acute phase and a
Th1 dominance in the chronic phase (Grewe et al., 1998). In
addition, the Th17 and Th22 subtypes have been described to
participate in the pathogenesis of AD (Toda et al., 2003; Koga
et al., 2008; Nograles et al., 2009; Eyerich et al., 2011).
Although Th17 cells have been found to be elevated in
peripheral blood and in acute lesions of AD patients, Th22
(and Tc22) cells were also detected in chronic AD lesions. The
exact role of both cell types is still not clear. For example,
IL-17 levels are much lower in AD than in psoriasis, which
might be due to the inhibitory effect of Th2 cytokines on IL-17
secretion (Toda et al., 2003; Eyerich et al., 2009; Nograles
et al., 2009; Gittler et al., 2012). As IL-17 promotes the release
of antimicrobial peptides by keratinocytes, the reduced IL-17
levels render AD patients susceptible to bacterial skin
infection while this is not common in psoriasis (Guttman-
Yassky et al., 2008). On the other hand, Th22 counts and
IL-22 mRNA levels are markedly higher in AD than in psoriasis
(Nograles et al., 2009). IL-22 inhibits the terminal differ-
entiation of keratinocytes, both directly and by inducing
other IL-10 family cytokines, like IL-20, in keratinocytes
(Boniface et al., 2005; Tohyama et al., 2009; Wolk et al.,
2009a, b). Similar to IL-17, IL-22 promotes the production of
antimicrobial peptides and chemokines, although with lower
potency than IL-17 (Wolk et al., 2004; Nograles et al., 2008;
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Figure 3. Monocyte-derived IL-23 is important for the alpha-chain of the nascent polypeptide-associated complex (a-NAC)-induced IL-17 secretion. Peripheral
blood mononuclear cells (PBMCs) were stimulated with a-NAC (2.5mg ml–1) for 4 hours and relative levels of mRNA were determined by reverse-transcriptase–
quantitative PCR (RT-qPCR) and normalized to glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA (a). PBMCs were stimulated with a-NAC
(2.5mg ml–1), IL-2 (50U ml–1), or a combination of both for 72 hours. IL-23 levels were measured by ELISA (b). PBMCs were preincubated with anti-IL-23 p19
antibody or the isotype control, followed by stimulation with a-NAC (2.5mg ml–1), IL-2 (50 U ml–1), or a combination of both for 72 hours. IL-17 and
IL-22 were measured by ELISA (c). Medians are shown. *Po0.05, **Po0.01.
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Tohyama et al., 2009). Although CD4þ T cells outnumber
CD8þ T cells in AD lesions, the latter have been shown to
initiate skin inflammation (Hennino et al., 2007), to infiltrate
the epidermis of lesional skin in AD and to contribute to
secretion of cytokines involved in atopic skin pathology like
IL-13, IL-22, and IFN-g (Hijnen et al., 2012).
Although it is typical for exogenous allergens to induce Th2
responses, this might not be true for autoallergens. Autoaller-
gens are self-proteins that elicit IgE responses in a subgroup of
AD patients and they have been discussed to exaggerate
disease activity just as exogenous allergens can do (Werfel and
Kapp, 1998; Valenta et al., 2000, 2009). Autoallergens may
be released in inflamed skin or after scratching and may thus
be accessible to immune cells. For human manganese
superoxide-dismutase, upregulation in inflammatory skin
diseases has been shown, which was not restricted to AD.
Nevertheless, IgE sensitization toward human manganese
superoxide-dismutase was specific for AD patients (Schmid-
Grendelmeier et al., 2005). Thioredoxin, another autoallergen
and homologue of the Malassezia sympodialis allergen Mala
s 13, is released from keratinocytes after stimulation with
IFN-g (Balaji et al., 2011).
a-NAC has been shown to induce IFN-g secretion in PBMCs
from AD patients and healthy donors. This could in turn
damage epithelial cells treated with the PBMC supernatants
(Mittermann et al., 2008). Here, we could show that a-NAC
induces the T-cell cytokines IL-17 and IL-22 in addition to
IFN-g. mRNA expression of IFN-g and IL-17 was also
upregulated with a-NAC alone and cytokine secretion was
amplified when a-NAC was combined with IL-2. Stimulation
of isolated CD4þ T cells yielded no or very low cytokine
secretion, while the stimulation of PBMCs was much more
effective. This could be explained by the strong Toll-like
receptor (TLR)-2-dependent activation of monocytes and
dendritic cells by a-NAC (Hradetzky et al., 2013), which
may be needed for a full activation of T cells. As monocytes
and inflammatory dendritic epidermal cells were equally
efficient in terms of IL-12 secretion and, subsequently, IFN-g
induction in CD4þ T cells (unpublished data and Hradetzky
et al., 2013), we used monocytes as easily available model
cells for further experiments.
In addition to the importance of IL-12 for the IFN-g response
to a-NAC, we have observed before, we could now show
upregulation of IL-23 expression by a-NAC in PMBCs as well
as reduced IL-17 secretion when PBMCs were pre-treated with
a blocking IL-23 antibody. In contrast, IL-22 secretion was not
significantly affected by this pre-treatment, which is in agree-
ment with former studies showing that Th22-derived IL-22
is not dependent on IL-23 (Zenewicz and Flavell, 2011),
although there are some studies pointing to an involvement of
IL-23 in IL-22 secretion in vivo (Siegemund et al., 2009;
Graham et al., 2011). The different impact of other monocyte-
derived cytokines such as IL-1b, IL-6, and tumor necrosis
factor-a on IL-17 and IL-22 production by CD4þ T cells
could explain this difference (Volpe et al., 2008; Duhen et al.,
2009). These findings further underline the importance of
monocytes for cytokine induction by a-NAC.
Another finding of our study is the STAT3 dependency of
the effects of a-NAC on PBMCs. STAT3 phosphorylation was
most pronounced when T-cell cytokine secretion was induced
most efficiently. Conversely, if cells were pre-treated with the
specific STAT3 inhibitor Stattic (Schust et al., 2006; Samavati
et al., 2009), cytokine secretion was greatly reduced. STAT3 is
an essential transcription factor for Th17 cells, it is important
for the differentiation of this cell type and also for IL-17
expression, as it directly binds to the Il17a locus and regulates
expression of the master transcription factor of Th17 cells,
retinoic acid-related orphan receptor-gt (Chen et al., 2006;
Yang et al., 2007). In agreement with this, the treatment of
PBMCs with Stattic led to reduced IL-17 expression and
secretion and further to a decrease in IL-22 and IFN-g
secretion. The inhibitory effect of Stattic may be due to
STAT3 signaling downstream of TLR-2, which has been
shown for TLR-2 activation by heat shock protein 60
(HSP60; Zanin-Zhorov et al., 2005). This is interesting, as
HSP60 is an intracellular chaperone and autoantigen like
a-NAC and T-cell reactivity to HSP60 has been shown in AD
patients (Kapitein et al., 2013). In addition, there are other
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Figure 4. Stimulation with the alpha-chain of the nascent polypeptide-
associated complex (a-NAC) leads to signal transducer and activator of
transcription 3 (STAT3) phosphorylation in peripheral blood mononuclear
cells (PBMCs). PBMCs from 26 donors were stimulated with a-NAC (2.5mgml–1),
IL-2 (50U ml–1), or a combination of both for 30minutes. Western blots for
phospho-STAT3 and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) were
performed. One representative experiment is shown (a). Integrated density values
(IDV) of phospho-STAT3 bands were normalized to the corresponding GAPDH
bands. Medians are shown (b). *Po0.05, **Po0.01.
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findings pointing to the fact that autoantigens or danger-
associated molecular patterns may bind different epitopes on
TLRs than exogenous antigens or pathogen-associated
molecular patterns do. For example, TLR-4 mutations, which
make the receptor less responsive to the pathogen-associated
molecular pattern, lipopolysaccharide (LPS) resulted in
enhanced activation of TLR-4 downstream signaling molec-
ules by the danger-associated molecular pattern fibrinogen
(Hodgkinson et al., 2008). Other danger-associated molecular
patterns need additional co-receptors, e.g., for receptor
activation by hyaluronic acid, a complex of TLR-4, MD-2
and, unlike for LPS, CD44 is required (Taylor et al., 2007).
Consequently, autoantigens may activate distinct signaling
pathways and cause different outcomes compared with
exogenous antigens (Piccinini and Midwood, 2010).
As many of the studies on endogenous TLR ligands have
been performed with recombinant proteins derived from
Escherichia coli (Erridge, 2010), the issue of contaminants
has to be taken into account. We have used a highly purified
a-NAC preparation, containing 1.9 ng LPS per mg protein, and
performed control experiments to rule out cytokine induction
by the remaining LPS (see Supplementary Figure S2 online).
Nevertheless, we cannot exclude interaction of a-NAC with
bacterial components. In fact, such an interaction has been
suggested as a factor promoting sensitization to different
aeroallergens, such as Fel d 1 and Can f 6 (Herre et al.,
2013), and for some of the proposed endogenous TLR ligands,
such as HSPs and serum amyloid A (Erridge, 2010). Such a
pathogen-associated molecular pattern–sensitizing function of
a-NAC might provide a link between cell damage in atopic
skin inflammation and microbial colonization of the skin.
Furthermore, a-NAC has the ability to form aggregates with
HSPs or DNA, which might further enhance its immunogenic
potential (Mossabeb et al., 2002; Wang et al., 2010).
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Figure 5. Signal transducer and activator of transcription 3 (STAT3) is essential for the alpha-chain of the nascent polypeptide-associated complex (a-NAC)-
induced cytokine secretion. Peripheral blood mononuclear cells (PBMCs) were preincubated with 20mM STAT3-inhibitor (Stattic) or the solvent DMSO alone and
then stimulated with a-NAC (2.5mg ml–1), IL-2 (50 U ml–1), or a combination of both for 30 minutes and blotted as described above. One representative experiment
of 10 independent experiments from different donors is shown in (a) and integrated density values (IDVs) of phospho-STAT3 normalized to glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) are shown in (b). PBMCs were preincubated with 5mM Stattic or DMSO for 30 minutes and then stimulated with a-NAC
(2.5mg ml–1), IL-2 (50 U ml–1), or a combination of both for 72 hours. Supernatants were measured for levels of IFN-g (n¼ 16), IL-17 (n¼13), and IL-22 (n¼15) by
ELISA (c) and 7-AAD-staining was performed (n¼ 6) (d). PBMCs were pre-treated with Stattic as described above and stimulated with Staphylococcus enterotoxin
B. Supernatants were analyzed by ELISA (e). Medians are shown. *Po0.05, **Po0.01, ***Po0.001. 7-AAD, 7-aminoactinomycin D.
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Although the pro-inflammatory cytokines IFN-g, IL-17, and
IL-22 could be induced in PBMCs from control donors and AD
patients in comparable amounts, a clear difference was
observed for IL-10 secretion. PBMCs from a-NAC-sensitized
AD patients produced significantly lower levels of this anti-
inflammatory cytokine compared with PBMCs from control
donors and non-sensitized AD patients. As monocytes were
the main producers of a-NAC-induced IL-10, this again points
to the involvement of innate immune cells in initiation or
perpetuation of autoallergic reactions. In fact, there are hints
on genetic and functional differences between innate immune
receptors from AD patients and from healthy subjects (Novak
et al., 2007; Niebuhr et al., 2008, 2009). A possible mecha-
nism, linking sensitization to a-NAC and the monocyte
response toward the autoallergen, could lie in the high-
affinity IgE receptor-mediated activation of these cells.
Novak et al. (2001) have shown high-affinity IgE receptor-
dependent IL-10 secretion by monocytes, which was,
however, higher in cells from atopic patients than from
non-atopic donors. On the other hand, a higher number of
IL-10-secreting allergen-specific T cells from non-allergic
compared with allergic donors has been shown (Akdis et al.,
2004). Yet, the mechanisms and the role of IL-10 induction
by autoallergens have to be further investigated in future
studies.
The a-NAC-induced pro-inflammatory cytokines IFN-g,
IL-17, and IL-22 are all known to act on keratinocytes and
can in turn lead to increased apoptosis or reduced differentia-
tion of these cells. This may start a vicious circle of even more
autoallergen release, which again promotes the ongoing
inflammation. Therefore, understanding the mechanisms by
which autoallergens influence the immune response are
important for future studies and therapeutic approaches and
we provided a further piece of the picture.
MATERIALS AND METHODS
Generation of recombinant a-NAC
Recombinant a-NAC was expressed in Escherichia coli as a soluble
protein and purified by means of nickel affinity chromatography as
described previously (Mossabeb et al., 2002; Mittermann et al., 2008).
The LPS concentration determined by LAL-Assay (Haemochrom
Diagnostica, Essen, Germany) was 2.6 ngml–1 in the stock solution,
corresponding to 1.9 ng per mg protein, which results in 5 pgml–1 LPS
in the working concentration of a-NAC.
Blood donors
Blood was obtained from AD patients that were recruited from the
outpatient clinic from the Department of Dermatology, Allergy and
Venerology, Hannover, Germany, after having received written
informed consent. Patients had a mean age of 40, mean total IgE
values of 3,766 kU l–1 and mean SCORAD of 38 and were not under
any immunosuppressive treatment. Patients were tested for IgE
sensitization to a-NAC by ELISA. Optical density values at least 2.5
times higher than the negative control sera were regarded as positive.
Buffy coats from healthy voluntary blood donors provided by the
institute of transfusion medicine, Hannover Medical School, were
used as control donors. The study has been approved by the local
ethic committee of Hannover Medical School and was conducted
according to Declaration of Helsinki principles.
Preparation of cells
PBMCs, monocytes, and CD4þ T cells were isolated as described in
the Supplementary Materials and Methods online.
Stimulation of the cells
The following stimulants were used: a-NAC (2.5mg ml–1), IL-2 (50 U
ml–1, Roche Applied Science, Mannheim, Germany), LPS (5 pg ml–1,
Sigma-Aldrich, Deisenhofen, Germany). Cells were stimulated
30 minutes for protein extraction, 8 hours for RNA isolation, and
3 days for generation of supernatants.
Blocking experiments
STAT3 inhibition was performed by pre-treating the cells with the
specific inhibitor Stattic (Calbiochem, Merck, Darmstadt, Germany).
Owing to the short incubation time, 20mM Stattic were used for
protein extraction. For longer incubations (RNA and supernatants),
5mM Stattic were used. To exclude toxicity of the inhibitor, PBMCs
were treated 3 days with 5mM Stattic and viability was assessed by
7-aminoactinomycin D staining (BD Biosciences, Bedford, MA).
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Figure 6. Peripheral blood mononuclear cells (PBMCs) of the alpha-chain of
the nascent polypeptide-associated complex (a-NAC)-sensitized atopic
dermatitis (AD) patients fail to secrete IL-10 in response to a-NAC. PBMCs
from AD patients and non-allergic donors were stimulated with a-NAC
(2.5mg ml–1), IL-2 (50U ml–1), or a combination of both for 72 hours. AD,
a-NAC-sensitized: open boxes (n¼ 11), controls: grey boxes (n¼18), AD, not
a-NAC-sensitized: striped boxes (n¼12) (a). PBMCs, monocytes, and CD4þ
T cells from non-sensitized donors were stimulated with a-NAC (2.5mg ml–1),
IL-2 (50U ml–1), or a combination of both for 72 h (b). Supernatants were
analyzed for levels of IL-10 by ELISA. Medians are shown. Groups were
compared by Mann–Whitney test. *Po0.05, **Po0.01. ns, not significant.
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Quantitative real-time PCR, ELISA, western blot
These methods are described in the Supplementary Materials and
Methods online.
Statistical analyses
Statistical analysis was performed using Wilcoxon signed rank test or
Mann–Whitney test for comparison of different groups (GraphPad
Prism, San Diego, CA).
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